Apollo Hospitals Brings Next-Generation Lysin Science to India's Fight Against AMR - Collaborates with Precisio Biotix
Jul 21, 2026
Hyderabad (Telangana) [India], July 21: Apollo Hospitals today announced a strategic collaboration with Precisio Biotix to accelerate the development and clinical adoption of lysin-based antimicrobials in India - marking a significant step forward in combating antimicrobial resistance (AMR). This partnership will focus on translational research, clinical validation, and potential deployment pathways for lysin-based therapies across Apollo's network, with a focus on infectious diseases where existing treatment options are limited.
Read More...
